Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
Nov. 30, 2017
Nov. 30, 2016
CURRENT    
Cash and cash equivalent $ 1,965,043 $ 192,826
Accounts receivable, net 36,412 32,534
Inventory 157,303 7,323
Prepaid expenses and other receivables 6,648 50,037
Total Current Assets 2,165,406 282,720
Deferred financing costs 0 36,874
Property and equipment, net 26,951 50,496
TOTAL ASSETS 2,192,357 370,090
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 393,341 245,911
Unsecured convertible debentures (net of deferred financing costs of $nil and $35,769), respectively 40,357 1,117,771
Derivative liabilities 539,860 0
Total Current Liabilities 973,558 1,363,682
Long term secured convertible debentures 892,176 0
Total Liabilities 1,865,734 1,363,682
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, nil issued and outstanding (2016 - nil). 0 0
Common stock, $0.001 par value 200,000,000 shares authorized, 93,014,134 issued and outstanding (2016: 55,104,493) 93,014 55,105
Additional paid-in capital 31,365,097 27,307,274
Accumulated deficit (31,098,864) (28,298,613)
Accumulated other comprehensive loss (32,624) (57,358)
Total Stockholders' Equity (Deficiency) 326,623 (993,592)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) $ 2,192,357 $ 370,090